Atani provides a unique, focused investment opportunity. Our business strategy is to license, develop and commercialize novel cancer drugs for the Japanese market. The Japanese pharmaceutical market represents a growing, attractive, and underserved market for pharmaceutical drugs, particularly in the area of cancer.